(S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One

2 trials Orphan designation

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

10 Countries

Phase III

Phase III: 2

Sponsors using this IMP

PTC Therapeutics Inc. 2

All trials

2 total

A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria Ended

2023-509229-31-00 Phase III 10 countries PTC Therapeutics Inc.
A Phase 3, Randomized, Crossover, Open-Label, Active-Controlled Study of Sepiapterin versus Sapropterin in Participants With Phenylketonuria… Ended

2023-506238-61-00 Phase III 9 countries PTC Therapeutics Inc.

Showing 1–2 of 2 trials

← All drugs A–Z